Studies indicate that 5–15% of sPD patients carry β-glucocerebrosidase (GBA1) heterozygous gene mutations, making them the most prevalent genetic risk factor for sPD to be identified32–35. The gene discussed is GBA1; the disease is Platelet storage pool disease.